Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 11/20 | 0.77 |
| ▸ | TSHR | P16473 | 9/20 | 0.77 |
| ▸ | HPGD | P15428 | 9/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.77 |
| ▸ | CASP1 | P29466 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | RECQL | P46063 | 3/20 | 0.56 |
| ▸ | TTR | P02766 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | THRB | P10828 | 3/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.55 |
| ▸ | HTR1A | P08908 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL54380 | 0.87 | HSD17B10 (1.00) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL29364629 | 0.87 | HSD17B10 (1.00) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL11879785 | 0.84 | HSD17B10 (0.57) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL30631745 | 0.80 | HSD17B10 (0.77) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL11832897 | 0.80 | HSD17B10 (0.77) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL9623619 | 0.80 | HSD17B10 (0.60) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL11144843 | 0.80 | HSD17B10 (0.59) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL11713810 | 0.80 | HSD17B10 (0.59) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL10771021 | 0.80 | HSD17B10 (0.59) | HSD17B10TSHRHPGDMAPK1CASP1 | |
| SCHEMBL827930 | 0.79 | HSD17B10 (1.00) | HSD17B10TSHRHPGDMAPK1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7179849-B2 | Antimicrobial compositions containing colloids of oligodynamic metals | C. R. BARD, INC. (US) | 2007-02-20 | — | — | US | claimed |
| US-20050042266-A1 | Cyanoacrylate compositions containing anti-microbial agent | CLOSURE MEDICAL CORPORATION (US) | 2005-02-24 | — | — | US | claimed |
| EP-1508601-A1 | Cyanoacrylate compositions containing anti-microbial agent | Closure Medical Corporation (US) | 2005-02-23 | — | — | EP | claimed |
| EP-2948256-B1 | ANTISEPTIC APPLICATOR | CAREFUSION 2200 INC (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20200299671-A1 | IMMOBILIZED MULTI-ENZYMATIC HALOGENATION SYSTEM | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2020-09-24 | — | — | US | disclosed |
| EP-2173428-B1 | FOLEY CATHETER HAVING STERILE BARRIER | BARD INC C R (US) | 2018-10-10 | — | — | EP | disclosed |
| CN-103338732-B | Feminine care absorbent article for use in warm climates | 金伯利-克拉克环球有限公司 | 2016-08-10 | — | — | CN | disclosed |
| EP-2948256-A1 | ANTISEPTIC APPLICATOR | CareFusion 2200 Inc. (US) | 2015-12-02 | — | — | EP | disclosed |
| CN-104955585-A | ANTISEPTIC APPLICATOR | CAREFUSION 2200 INC | 2015-09-30 | — | — | CN | disclosed |
| US-9119946-B2 | Antiseptic applicator | CAREFUSION 2200, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-9084838-B2 | Feminine care absorbent article for use in warm climates | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2015-07-21 | — | — | US | disclosed |
| US-20010016589-A1 | Mixture of chlorhexidine, quaternary ammonium salt and chlorinated phenol | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE | 2001-08-23 | — | — | US | disclosed |
| EP-0664014-B1 | NLO SIDE CHAIN POLYMERS HAVING LOW OPTICAL LOSS | AKZO NOBEL NV (NL) | 1998-08-19 | — | — | EP | disclosed |
| EP-0824096-A2 | Process for the preparation of halogenated (meth)acrylic esters and poly (meth) arcylates obtained with said (meth)acrylic esters | Akzo Nobel N.V. (NL) | 1998-02-18 | — | — | EP | disclosed |
| EP-0664014-A1 | NLO SIDE CHAIN POLYMERS HAVING LOW OPTICAL LOSS | Akzo Nobel N.V. (NL) | 1995-07-26 | — | — | EP | disclosed |
| WO-1994008269-A1 | NLO SIDE CHAIN POLYMERS HAVING LOW OPTICAL LOSS | AKZO NOBEL N.V. (NL) | 1994-04-14 | — | — | WO | disclosed |
| EP-0319990-B1 | Process for preparing composite membranes | DU PONT (US) | 1993-10-20 | — | — | EP | disclosed |
| EP-0319990-A2 | Process for preparing composite membranes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-14 | — | — | EP | disclosed |
| US-4783346-A | INTERFACES, POLYAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-11-08 | — | — | US | disclosed |
| US-4155946-A | CATALYST CONSISTS OF A NICKEL COMPOUND, A TRIALKYL ALUMINUM COMPOUND; PHOSPHOROUS COMPOUND AND A HALOGENATED PHENOL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050042266-A1 | Cyanoacrylate compositions containing anti-microbial agent | CLSPN, PCNA, CDC73 | HSD17B10 3029/4885TSHR 4429/4885HPGD 2728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.